Literature DB >> 16625199

Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice.

Maya Saleh1, John C Mathison, Melissa K Wolinski, Steve J Bensinger, Patrick Fitzgerald, Nathalie Droin, Richard J Ulevitch, Douglas R Green, Donald W Nicholson.   

Abstract

Caspases function in both apoptosis and inflammatory cytokine processing and thereby have a role in resistance to sepsis. Here we describe a novel role for a caspase in dampening responses to bacterial infection. We show that in mice, gene-targeted deletion of caspase-12 renders animals resistant to peritonitis and septic shock. The resulting survival advantage was conferred by the ability of the caspase-12-deficient mice to clear bacterial infection more efficiently than wild-type littermates. Caspase-12 dampened the production of the pro-inflammatory cytokines interleukin (IL)-1beta, IL-18 (interferon (IFN)-gamma inducing factor) and IFN-gamma, but not tumour-necrosis factor-alpha and IL-6, in response to various bacterial components that stimulate Toll-like receptor and NOD pathways. The IFN-gamma pathway was crucial in mediating survival of septic caspase-12-deficient mice, because administration of neutralizing antibodies to IFN-gamma receptors ablated the survival advantage that otherwise occurred in these animals. Mechanistically, caspase-12 associated with caspase-1 and inhibited its activity. Notably, the protease function of caspase-12 was not necessary for this effect, as the catalytically inactive caspase-12 mutant Cys299Ala also inhibited caspase-1 and IL-1beta production to the same extent as wild-type caspase-12. In this regard, caspase-12 seems to be the cFLIP counterpart for regulating the inflammatory branch of the caspase cascade. In mice, caspase-12 deficiency confers resistance to sepsis and its presence exerts a dominant-negative suppressive effect on caspase-1, resulting in enhanced vulnerability to bacterial infection and septic mortality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625199     DOI: 10.1038/nature04656

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  114 in total

1.  The inflammasome: in memory of Dr. Jurg Tschopp.

Authors:  M Dagenais; A Skeldon; M Saleh
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 2.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 3.  Non-caspase proteases: triggers or amplifiers of apoptosis?

Authors:  Karen Schrader; Jisen Huai; Lars Jöckel; Carolin Oberle; Christoph Borner
Journal:  Cell Mol Life Sci       Date:  2010-02-19       Impact factor: 9.261

Review 4.  Pyroptotic cell death defends against intracellular pathogens.

Authors:  Ine Jorgensen; Edward A Miao
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 5.  Inhibiting the inflammasome: one domain at a time.

Authors:  Andrea Dorfleutner; Lan Chu; Christian Stehlik
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

6.  Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis.

Authors:  Celine A Beamer; Benjamin P Seaver; David M Shepherd
Journal:  Toxicol Sci       Date:  2012-01-23       Impact factor: 4.849

Review 7.  Mediators of endoplasmic reticulum stress-induced apoptosis.

Authors:  Eva Szegezdi; Susan E Logue; Adrienne M Gorman; Afshin Samali
Journal:  EMBO Rep       Date:  2006-09       Impact factor: 8.807

Review 8.  Genetics-squared: combining host and pathogen genetics in the analysis of innate immunity and bacterial virulence.

Authors:  Jenny Persson; Russell E Vance
Journal:  Immunogenetics       Date:  2007-09-14       Impact factor: 2.846

9.  Regulation of apoptosis by the unfolded protein response.

Authors:  Andrew Fribley; Kezhong Zhang; Randal J Kaufman
Journal:  Methods Mol Biol       Date:  2009

10.  Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection.

Authors:  Garabet Yeretssian; Karine Doiron; Wei Shao; Blair R Leavitt; Michael R Hayden; Donald W Nicholson; Maya Saleh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.